You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKesson
AstraZeneca
Merck
Boehringer Ingelheim
Medtronic

Last Updated: April 10, 2020

DrugPatentWatch Database Preview

Immunoglobulin g - Biologic Drug Details


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Recent Clinical Trials for immunoglobulin g

Identify potential brand extensions & biosimilar entrants

SponsorPhase
Massimo GirardisPhase 3
Melanoma Institute AustraliaPhase 2
Wuhan Union Hospital, ChinaN/A

See all immunoglobulin g clinical trials

Recent Litigation for immunoglobulin g

Identify key patents and potential future biosimilar entrants

District Court Litigation
Case NameDate
Life Technologies Corporation v. Ebioscience Inc.2010-10-12
PIECZENIK v. BAYER CORPORATION2010-05-04
eBioscience Corporation v. Invitrogen Corporation2008-09-22

See all immunoglobulin g litigation

Patent Text Search: US Patents for immunoglobulin g

These patents were identified by searching patent claims

Supplementary Protection Certificates for immunoglobulin g

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
01830022 Spain   Start Trial PRODUCT NAME: PADELIPORFINA; NATIONAL AUTHORISATION NUMBER: EU/1/17/1228; DATE OF AUTHORISATION: 20171110; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/17/1228; DATE OF FIRST AUTHORISATION IN EEA: 20171110
90017-5 Sweden   Start Trial PRODUCT NAME: DI-POTASSIUM SALT OF PADELIPORFIN; REG. NO/DATE: EU/1/17/1228 20171114
C/GB10/044 United Kingdom   Start Trial PRODUCT NAME: DENOSUMAB, IMMUNOGLOBULIN G2, ANTI-(HUMAN TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 11 (HUMAN OSTEOCLAST DIFFERENTIATION FACTOR)) HUMAN MONOCLONAL AMG162 HEAVY CHAIN), DISULPHIDE WITH HUMAN MONOCLONAL AMG162 LIGHT CHAIN, DIMER.; REGISTERED: UK EU/1/10/618/001 20100526; UK EU/1/10/618/002 20100526; UK EU/1/10/618/003 20100526; UK EU/1/10/618/004 20100526
C00073 Luxembourg   Start Trial PRODUCT NAME: TOOKAD - PADELIPORFIN; AUTHORISATION NUMBER AND DATE: EU/1/17/1228 20171114
>Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Boehringer Ingelheim
Mallinckrodt
AstraZeneca
Merck
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.